Magnetic resonance imaging to assess blood-brain barrier damage in murine trypanosomiasis

American Journal of Tropical Medicine and Hygiene

Volumn 84, Issue 2, 2011, Pages 344-350

  Rodgers, Jean ^a   McCabe, Christopher ^a   Gettinby, George ^b   Bradley, Barbara ^a   Condon, Barrie ^c   Kennedy, Peter G E ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL; CONTROLLED STUDY; FEMALE; INFLAMMATION; LEUKOCYTE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TRYPANOSOMIASIS; AFRICAN TRYPANOSOMIASIS; ANIMAL; BRAIN; DISEASE COURSE; PARASITOLOGY; PATHOLOGY; TRYPANOSOMA BRUCEI;

ANIMALIA; MURINAE; MUS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MICE; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 79952693190     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0487     Document Type: Article

References (39)

1. Kennedy PGE, 2004. Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 113: 496-504. (Pubitemid 38542496)
2. Kennedy PGE, 2008. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann Neurol 64: 116-126.
3. Apted FIC, 1970. Clinical manifestations and diagnosis of sleeping sickness. Mulligan HW, ed. The African Trypanosomiases.London, UK: Allen & Urwin, 661-683.
4. Rodgers J, 2009. Human African trypanosomiasis, chemotherapy and CNS disease. J Neuroimmunol 211: 16-22.
5. Adams JH, Graham DI, 1998. Virus and other infections. Adams JH, Graham DI, eds. An Introduction to Neuropathology.Edinburgh, Scotland: Churchhill Livingstone, 94-117.
6. Atouguia JLM, Kennedy PGE, 2000. Neurological aspects of human African trypanosomiasis. Davies LE, Kennedy PGE, eds. Infectious Diseases of the Nervous System. Oxford, UK: Butterworth-Heinemann, 321-372.
7. Adams JH, Haller L, Boa FY, Doua F, Dago A, Konian K, 1986. Human African trypanosomiasis (T. b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. Neuropathol Appl Neurobiol 12: 81-94. (Pubitemid 16168225)
8. Schmidt H, 1983. The pathogenesis of trypanosomiasis of the CNS. Studies on parasitological and neurohistological findings in Trypanosoma rhodesiense infected vervet monkeys. Virchows Arch A Pathol Anat Histopathol 399: 333-343. (Pubitemid 13068251)
9. Fink E, Schmidt H, 1979. Meningoencephalitis in chronic Trypanosoma brucei rhodesiense infection of the white mouse. Tropenmed Parasitol 30: 206-211. (Pubitemid 9196688)
10. Poltera AA, Hochmann A, Lambert PH, 1982. Trypanosoma brucei gambiense: cerebral immunopathology in mice. Acta Trop 39: 205-218. (Pubitemid 12002221)
11. Jennings FW, McNeil PE, Ndung'u JM, Murray M, 1989. Trypanosomiasis and encephalitis: possible aetiology and treatment. Trans R Soc Trop Med Hyg 83: 518-519. (Pubitemid 19212074)
12. Philip KA, Dascombe MJ, Fraser PA, Pentreath VW, 1994. Blood-brain barrier damage in experimental African trypanosomiasis. Ann Trop Med Parasitol 88: 607-616.
13. Mulenga C, Mhlanga JD, Kristensson K, Robertson B, 2001. Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol 27: 77-85. (Pubitemid 32291190)
14. Sabbah P, Brosset C, Imbert P, Bonardel G, Jeandel P, Briant JF, 1997. Human African trypanosomiasis: MRI. Neuroradiology 39: 708-710. (Pubitemid 27425063)
15. Gill DS, Chatha DS, Carpio-O'Donovan R, 2003. MR imaging findings in African trypansomiasis. AJNR Am J Neuroradiol 24: 1383-1385. (Pubitemid 37012835)
16. Kager PA, Schipper HG, Stam J, Majoie CB, 2009. Case report: magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature. Am J Trop Med Hyg 80: 947-952.
17. Braakman HM, van de Molengraft FJ, Hubert WW, Boerman DH, 2006. Lethal African trypanosomiasis in a traveler: MRI and neuropathology. Neurology 66: 1094-1096. (Pubitemid 44044798)
18. Sternberg JM, Rodgers J, Bradley B, MacLean L, Murray M, Kennedy PG, 2005. Meningoencephalitic African trypanosomiasis: brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology. J Neuroimmunol 167: 81-89. (Pubitemid 41242290)
19. Abbott NJ, Chugani DC, Zaharchuk G, Rosen BR, Lo EH, 1999. Delivery of imaging agents into brain. Adv Drug Deliv Rev 37: 253-277. (Pubitemid 29164512)
20. Kennedy PGE, Rodgers J, Jennings FW, Murray M, Leeman SE, Burke JM, 1997. A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proc Natl Acad Sci USA 94: 4167-4170. (Pubitemid 27180517)
21. Rodgers J, Stone TW, Barrett MP, Bradley B, Kennedy PG, 2009. Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis. Brain 132: 1259-1267.
22. Engelhardt B, 2008. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des 14: 1555-1565. (Pubitemid 352002983)
23. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B, Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105: 586-592.
24. Grab DJ, Nikolskaia O, Kim YV, Lonsdale-Eccles JD, Ito S, Hara T, Fukuma T, Nyarko E, Kim KJ, Stins MF, Delannoy MJ, Rodgers J, Kim KS, 2004. African trypanosome interactions with an in vitro model of the human blood-brain barrier. J Parasitol 90: 970-979. (Pubitemid 40247375)
25. Nikolskaia OV, de A Lima A, Kim YV, Lonsdale-Eccles JD, Fukuma T, Scharfstein J, Grab DJ, 2006. Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease. J Clin Invest 116: 2739-2747.
26. Ballabh P, Braun A, Nedergaard M, 2004. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16: 1-13. (Pubitemid 38569790)
27. Hawkins BT, Davis TP, 2005. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57: 173-185. (Pubitemid 41043883)
28. Bartholomaus I, Kawakami N, Odoardi F, Schlager C, Miljkovic D, Ellwart JW, Klinkert WE, Flugel-Koch C, Issekutz TB, Wekerle H, Flugel A, 2009. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462: 94-98.
29. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F, C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10: 514-523.
30. Ransohoff RM, 2009. Immunology: in the beginning. Nature 462: 41-42.
31. MacLean L, Odiit M, MacLeod A, Morrison L, Sweeney L, Cooper A, Kennedy PG, Sternberg JM, 2007. Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response. J Infect Dis 196: 1620-1628. (Pubitemid 351411959)
32. Amin DN, Rottenberg ME, Thomsen AR, Mumba D, Fenger C, Kristensson K, Buscher P, Finsen B, Masocha W, 2009. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. J Infect Dis 200: 1556-1565.
33. Masocha W, Robertson B, Rottenberg ME, Mhlanga J, Sorokin L, Kristensson K, 2004. Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. J Clin Invest 114: 689-694. (Pubitemid 39578759)
34. Kennedy PGE, Rodgers J, Bradley B, Hunt SP, Gettinby G, Leeman SE, de Felipe C, Murray M, 2003. Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice. Brain 126: 1683-1690. (Pubitemid 36834944)
35. Liao CW, Cho WL, Kao TC, Su KE, Lin YH, Fan CK, 2008. Blood-brain barrier impairment with enhanced SP, NK-1R, GFAP and claudin-5 expressions in experimental cerebral toxocariasis. Parasite Immunol 30: 525-534.
36. St'astny F, Skultetyova I, Pliss L, Jezova D, 2000. Quinolinic acid enhances permeability of rat brain microvessels to plasma albumin. Brain Res Bull 53: 415-420. (Pubitemid 32000818)
37. Sanderson L, Dogruel M, Rodgers J, Bradley B, Thomas SA, 2008. The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain. J Neurochem 107: 1136-1146.
38. Sanderson L, Dogruel M, Rodgers J, De Koning H, Thomas SA, 2009. Pentamidine movement across the murine blood-brain and blood-CSF barriers; effect of trypanosome infection, combination therapy, P-glycoprotein and MRP. J Pharmacol Exp Ther 329: 967-977.
39. World Health Organization, 1998. Control and Surveillance of African Trypanosomiaisis. World Health Organization Technical Report Series 881. Geneva, Switzerland: World Health Organization, 1-113.